Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 158(3): 437-41, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20870246

RESUMO

OBJECTIVE: To establish the relationship between vitamin D serum levels, pulmonary function, and asthma control in children. STUDY DESIGN: We studied the relationship between 25-hydroxy cholecalciferol [25(OH)D] concentrations and baseline spirometry and levels of asthma control, assessed according to Global Initiative for Asthma guidelines and the Childhood Asthma Control Test, in 75 children with asthma (age range 5-11 years; 43 males) in a cross-sectional study carried out during the winter and early spring. RESULTS: Only 9.4% of our children had a sufficient serum 25(OH)D (at least 30 to 40 ng/mL). A significant positive correlation was found between forced vital capacity percent predicted and serum 25(OH)D (r = 0.25, P = .040). This was true also for forced expiratory volume in 1 second, even though it was not statistically significant (r = 0.16, P = .157). Subjects with well-controlled asthma had higher serum levels of 25(OH)D than children with partially controlled or non-controlled asthma, with values of (median [Q1; Q3]) 22.2 (16.3; 25.4), 17.8 (11.8; 22.1) and 18.1 (15.0; 18.5), respectively (P = .023). Furthermore, a positive correlation was found between 25(OH)D and the Childhood Asthma Control Test (r = 0.28; P = .011). CONCLUSIONS: Our results indicate that hypovitaminosis D is frequent in children with asthma living in a Mediterranean country. In those children, lower levels of vitamin D are associated with reduced asthma control.


Assuntos
Asma/sangue , Asma/epidemiologia , Calcifediol/sangue , Deficiência de Vitamina D/epidemiologia , Biomarcadores/sangue , Criança , Pré-Escolar , Estudos Transversais , Feminino , Volume Expiratório Forçado , Humanos , Imunoglobulina E/sangue , Itália/epidemiologia , Masculino , Capacidade Vital
2.
J Pediatr ; 155(6): 940-1, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19914435

RESUMO

We describe a child who had anaphylactic hypersensitivity to imiglucerase therapy for Gaucher disease. Treatment was stopped and symptoms returned. After immune desensitization to imiglucerase using a rush protocol, the patient was able to resume treatment and has not had further hypersensitivity complications to date.


Assuntos
Anafilaxia/terapia , Dessensibilização Imunológica , Hipersensibilidade a Drogas/terapia , Doença de Gaucher/tratamento farmacológico , Glucosilceramidase/administração & dosagem , Anafilaxia/induzido quimicamente , Anafilaxia/diagnóstico , Criança , Hipersensibilidade a Drogas/diagnóstico , Hipersensibilidade a Drogas/etiologia , Doença de Gaucher/imunologia , Glucosilceramidase/efeitos adversos , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA